InMode (INMD) Enterprise Value (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | InMode | 3.41 | -384.57 Mn | 61.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.42% |
| Dec 31, 2025 | -66.77% |
| Sep 30, 2025 | -72.23% |
| Jun 30, 2025 | -7.50% |
| Mar 31, 2025 | 61.96% |
| Dec 31, 2024 | -394.41% |
| Sep 30, 2024 | 19.19% |
| Jun 30, 2024 | 510.10% |
| Mar 31, 2024 | -120.47% |
| Dec 31, 2023 | 239.72% |
| Sep 30, 2023 | 218.45% |
| Jun 30, 2023 | -41.43% |
| Mar 31, 2023 | -121.40% |
| Dec 31, 2022 | 881.91% |
| Sep 30, 2022 | 118.80% |
| Jun 30, 2022 | -111.63% |
| Mar 31, 2022 | 80.67% |
| Dec 31, 2021 | -190.35% |
| Sep 30, 2021 | 136.57% |
| Jun 30, 2021 | 2,238.14% |
| Mar 31, 2021 | -102.60% |
| Dec 31, 2020 | 102.26% |
| Sep 30, 2020 | 273.35% |
| Jun 30, 2020 | 1,223.82% |
| Mar 31, 2020 | -100.97% |
| Dec 31, 2019 | 131.53% |
| Sep 30, 2019 | 539.77% |
| Jun 30, 2019 | 38.29% |
| Mar 31, 2019 | -225.24% |
| Dec 31, 2018 | 723.54% |
| Sep 30, 2018 | 112.03% |